Effect of Testing for IgG Avidity in the Diagnosis of Toxoplasma gondii Infection in Pregnant Women: Experience in a US Reference Laboratory
|
|
- Rosamond Bryant
- 6 years ago
- Views:
Transcription
1 1248 Effect of Testing for IgG Avidity in the Diagnosis of Toxoplasma gondii Infection in Pregnant Women: Experience in a US Reference Laboratory Oliver Liesenfeld, 1,2,3 Jose G. Montoya, 1,2 Sandra Kinney, 1 Cynthia Press, 1 and Jack S. Remington 1,2 1 Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, and 2 Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California; 3 Department of Medical Microbiology and Immunology of Infection, Institute for Infection Medicine, Benjamin Franklin Medical Center, Free University of Berlin, Berlin, Germany The usefulness of testing for IgG avidity in association with Toxoplasma gondii was evaluated in a US reference laboratory. European investigators have reported that high-avidity IgG toxoplasma antibodies exclude acute infection in the preceding 3 months. In this US study, 125 serum samples taken from 125 pregnant women in the first trimester were chosen retrospectively, because either the IgM or differential agglutination (AC/HS) test in the Toxoplasma serologic profile suggested or was equivocal for a recently acquired infection. Of 93 (74.4%) serum samples with either positive or equivocal results in the IgM ELISA, 52 (55.9%) had high-avidity antibodies, which suggests that the infection probably was acquired before gestation. Of 87 (69.6%) serum samples with an acute or equivocal result in the AC/HS test, 35 (40.2%) had high-avidity antibodies. Forty women were given spiramycin, to prevent congenital transmission, and 7 (17.5%) had high-avidity antibodies. These findings highlight the value of testing a single serum sample obtained in the first trimester of pregnancy for IgG avidity. Infection with Toxoplasma gondii during pregnancy may lead to severe sequelae in the fetus [1]. At present, definitive serologic diagnosis of acute infection during gestation can be made only if paired serum samples reveal a significant increase in titer most often of IgG antibodies [2]. Such increasing titers are not commonly seen in US pregnant women, because no systematic serologic screening to detect seroconversion is done. Although successful screening programs have been used in France and Austria for many years [3, 4], in the United States, usually only a single serum sample is submitted for testing, frequently late in gestation. Because IgM antibodies may persist for months or even years after acute infection [5, 6], their greatest value is in determining that a pregnant woman was not infected recently. A negative result virtually rules out recent infection, unless serum samples are tested so late after infection that IgM antibody has disappeared or so early after the acute infection that an antibody response has not occurred or is not yet detectable [1, 2]. When Received 28 July 2000; revised 10 January 2001; electronically published 16 March Financial support: National Institutes of Health (grant AI-04717); Infectious Disease Fellowship from the German Ministry of Research and Technology to O.L. Reprints or correspondence: Dr. Jose G. Montoya, Research Institute, Palo Alto Medical Foundation, Ames Bldg., 795 El Camino Real, Palo Alto, CA (gilberto@leland.stanford.edu). The Journal of Infectious Diseases 2001;183: by the Infectious Diseases Society of America. All rights reserved /2001/ $02.00 results are positive, a number of additional serologic tests, including those for the detection of IgG [7, 8], IgA [9], and IgE [10] antibodies, and a combination of these tests, the Toxoplasma serologic profile (TSP) [11, 12], can help discriminate between recently acquired and distant infection. The differential agglutination (AC/HS) test most closely approaches a single reference standard test for the discrimination of recently acquired and distant infection [8]. However, at present in the United States, this test is done only by the Toxoplasma Serology Laboratory, Palo Alto Medical Foundation (TSL-PAMF; Stanford, CA), because the required antigen preparations are not commercially available. In addition, as is true for IgM antibodies, an acute pattern in the AC/HS test may persist for 11 year [8]. Recently, several tests for avidity of toxoplasma IgG antibodies have been introduced to help discriminate between recently acquired and distant infection [13 20]. The commercial tests are available in Europe but are not licensed in the United States. Results are based on the measurement of functional affinity of specific IgG antibodies [21]. IgG affinity, which initially is low after primary antigenic challenge, increases during subsequent weeks and months by antigen-driven B cell selection. Protein-denaturing reagents, including urea, are used to dissociate the antibody-antigen complex. The avidity result is determined by using the ratios of antibody titration curves of urea-treated and -untreated sample. We investigated the usefulness of testing for avidity of IgG antibodies in a US toxoplasma serology reference laboratory
2 JID 2001;183 (15 April) Toxoplasma IgG Avidity 1249 that processes serum samples primarily from pregnant women. In most cases, the physician requests information about the time of onset of the infection on the basis of results obtained from a single serum sample. Our goal was to compare results obtained in an IgG avidity test with those obtained in the IgM ELISA and AC/HS tests. Materials and Methods We retrospectively studied 125 serum samples taken from 125 pregnant women in the first trimester of gestation. The serum samples were submitted to the TSL-PAMF between September 1994 and September Serum samples had been routinely tested by the TSP, as described elsewhere [11, 12]. The TSP comprises the Sabin-Feldman dye test (DT) [7], double-sandwich IgM ELISA [22], IgA ELISA [9], IgE ELISA [10], IgE immunosorbent agglutination assay (ISAGA) [10], and AC/HS test [8]. The Sabin-Feldman DT is considered to be positive at any titer. The starting dilution was 1:16. The double-sandwich IgM ELISA method [22] has been used by our laboratory and other reference laboratories for 115 years. A result of 2.0 was interpreted as positive, as equivocal, and!1.7 as negative. The following titers were considered to be positive, negative, and equivocal, respectively, in the tests: IgA ELISA, 2.1 and 1.4 (equivocal, ); IgE ELISA, 11.8 and 1.4 (equivocal, ); and IgE ISAGA, 4 and 2 (equivocal, 3). The AC/HS test was interpreted, as described elsewhere [8], by comparing titers obtained with formalin-fixed tachyzoites (HS antigen) with those obtained with acetone-fixed tachyzoites (AC antigen; figure 1). IgG antibodies formed early in infection recognize stage-specific antigens in the AC preparation, which are distinct from those formed later in infection [8, 23]. Current interpretation of results in the TSP at the TSL-PAMF is as follows: serum samples obtained within the first 2 trimesters that are positive in the DT and negative in the IgM, IgA, and IgE ELISAs and reveal a chronic pattern in the AC/HS test are typically found in patients infected before gestation. The combination of high titers in the DT, positive IgM, IgA, and IgE ELISAs, and an acute pattern in the AC/HS test is highly suggestive of a recent infection. In contrast, the presence of a positive DT and IgM ELISA but a negative, low-positive, or equivocal result in the IgA and IgE ELISAs and IgE ISAGA and an equivocal pattern in the AC/HS test is more difficult to interpret, since it suggests infection before pregnancy but does not rule out recent infection. We selected consecutive serum samples in which the TSP had 1 test result that suggested the possibility of a recently acquired infection. This approach enabled us to evaluate the discriminatory power of testing for IgG avidity. To select serum samples for testing for IgG avidity, we used the following criteria: first, positive or equivocal results in the IgM ELISA or acute or equivocal pattern in the AC/HS test or second, results in the TSP that were not clearly consistent with an infection acquired in the distant or recent past. In some cases, interpretation of the TSP did not allow for clearcut discrimination between recently acquired and distant infection, even after a follow-up sample was tested in parallel with the first serum sample. IgG avidity was measured with the T. gondii IgG avidity EIA (Labsystems), and results were interpreted in accordance with the manufacturer s instructions. In brief, serum samples were diluted in 4-fold dilutions, according to their predetermined IgG titers. Serum samples were diluted and incubated in duplicate for 60 min at 37 C int. gondii coated microstrips. We incubated 1 well of each duplicate serum sample and of the negative, low avidity, and high avidity controls in PBS/Tween; the other well of each duplicate was incubated with avidity buffer containing urea. After a wash, antigen-bound IgG was bound by conjugate applied for 1 h at 37 C and was revealed by substrate. Optical densities were read at 405 nm. For each control and serum sample, we obtained 2 titration curves (1 for each sample incubated with PBS/Tween and 1 for samples incubated with avidity buffer). The distance between curves corresponds to the avidity percentage (e.g., the greater the distance in millimeters, the lower the avidity percentage that indicates low-avidity antibodies and vice versa). We interpreted avidity results as follows:!15%, low avidity (may be seen in acute primary infection with T. gondii); 15% 30%, borderline avidity (primary infection within the past 6 months is possible); and 130%, high avidity (excludes primary infection within the previous 3 months). A high-avidity result in the first 12 weeks of pregnancy essentially rules out a recently acquired infection during gestation. A low or equivocal IgG avidity result cannot be interpreted to mean that a person was infected recently with T. gondii, because low-avidity antibodies may persist for 15 months. Thus, when the Labsystems kit is used in the first trimester, only high-avidity antibodies are clinically meaningful. When available, we used follow-up serologic test results obtained 3 weeks apart from the initial serum sample and from serum samples obtained before the initial sample submitted to the TSL- PAMF to resolve discrepant results between individual tests. All such serum samples were run in each test in parallel. Results Figure 1. Criteria for interpretation of differential agglutination (AC [acetone-fixed tachyzoites]/hs [formalin-fixed tachyzoites]) test results. We studied serum samples taken from 125 pregnant women during the first trimester. Results in the IgM ELISA were positive in 81 (64.8%), equivocal in 12 (1.0%), and negative in 25 (20%) cases; an IgM ELISA titer could not be determined in 7 samples because of high background activity. In 42 (51.9%) of the 81 serum samples that were positive by IgM ELISA, the IgG avidity result was high (table 1), which indicates that in-
3 1250 Liesenfeld et al. JID 2001;183 (15 April) Table 1. Comparison of results of IgM ELISA and IgG avidity test in 118 serum samples taken from pregnant women during the first trimester. Avidity result Positive (n p 81) IgM ELISA result Equivocal (n p 12) Negative (n p 25) Low 16 (19.8) 0 4 (16.0) Borderline 23 (28.3) 2 (16.7) 7 (28.0) High 42 (51.9) 10 (83.3) 14 (56.0) NOTE. Data are no. (%) of serum samples. Because of high background in IgM ELISA, 7 serum samples were not included in the comparison. fection in those women occurred before gestation. In 16 (19.8%) of the 81 serum samples, IgG avidity was low. In addition, 93 (74.4%) of 125 serum samples had positive or equivocal results in the IgM ELISA (often interpreted as being suggestive of a recently acquired infection); IgG avidity results were high in 52 (55.9%), equivocal in 25 (26.9%), and low in 16 (17.2%). In 25 serum samples that were negative in the IgM ELISA, 4 (16.0%) had low avidity, 14 (56.0%) had high avidity, and 7 (28.0%) had equivocal avidity test results (table 1). Figure 2 compares results in the IgM ELISA with those in the IgG avidity test. Mean titers of T. gondii specific IgM antibodies were 4.1 in serum samples with low-avidity antibodies, 3.2 in serum samples with borderline avidity, and 2.6 in serum samples with highavidity antibodies. Each of the 4 serum samples that were negative in the IgM ELISA and that had low IgG avidity titers had IgG titers of 512 (table 2); 3 had an acute pattern in the AC/HS test, and each was negative by IgA ELISA (table 2). Follow-up serum samples were available for 2 patients but did not reveal significant increases in antibody titers. For patients with a positive IgM test, the AC/HS test was the sole test that was most helpful in distinguishing recently acquired from more distant infection. Of the 125 women who were in their first trimester of pregnancy, 33 (26.4%) had an acute AC/HS test result, 53 (42.4%) had an equivocal result, and 39 (31.2%) had a nonacute result. Of the 33 women with an acute result in the AC/HS test, 17 (51.5%) had low avidity, 12 (36.4%) had equivocal avidity, and 4 (12.1%) had high-avidity test results (table 3). In all, 87 (69.6%) of the 125 women had either an acute or equivocal result in the AC/HS test (often interpreted as being suggestive of a recently acquired infection); IgG avidity results in these were low in 21 (24.1%), equivocal in 31 (35.6%), and high in 35 (40.2%; table 3). Of the 39 women who had a nonacute AC/HS test result, 94.9% had a highavidity test result; 2 (5.1%) were equivocal by avidity test, and none had a low-avidity test result. In 85 (68.0%) of the 125 cases, the overall interpretation of the TSP by TSL-PAMF physicians (without inclusion of the avidity test) was consistent with an infection acquired before conception. For 40 (32.0%) of the 125 women, interpretation of results in the TSP did not allow us to rule out infection acquired during pregnancy or near conception. In these women, spiramycin was recommended in an attempt to prevent transmission of the parasite from mother to fetus. Testing of IgG avidity in serum samples from these 40 women revealed high avidity in 7 (17.5%), borderline avidity in 17 (42.5%), and low avidity in 16 (40.0%). Figure 2. Correlation of IgM titers with avidity test results in 118 serum samples taken from 188 pregnant women during the first trimester. Two data points are superimposed, because results in 2 serum samples were identical (borderline avidity and negative IgM test results).
4 JID 2001;183 (15 April) Toxoplasma IgG Avidity 1251 Table 2. Serological test results in serum samples obtained from pregnant women during their first trimester who had negative results in the IgM ELISA and low IgG avidity. Specimen Gestation, weeks Avidity, % IgG a IgM IgA IgE ELISA IgE ISAGA AC/HS (int) b /13200 (A) c /200 (A) b /400 (A) /400 (E) NOTE. A, acute pattern; AC/HS, differential agglutination test; E, equivocal pattern; int, interpretation; ISAGA, immunosorbent agglutination assay. For further explanation of the AC/HS test, see figure 1. a Reciprocal of serum dilution. b No significant increase in antibody titers was observed in follow-up serum samples obtained 4 weeks apart. c Serum sample obtained 8 weeks earlier revealed a negative result in the IgM ELISA and an equivocal pattern in the AC/HS test. Discussion Development of a serologic method to differentiate recent from more distant T. gondii infection in pregnant women by using a single serum sample has long been a goal of industry and academic investigators. Such a method would be of particular importance in the United States, where systematic serologic screening during pregnancy is not done. The lack of availability of serial serum samples from individual pregnant women in the United States has severely hampered research in this direction and has markedly compromised the ability of physicians to determine the risk for congenital infection. These problems led our group to develop a serologic test panel [11, 12] that assists in defining whether a positive IgM antibody test result for a given patient reflects recently acquired infection. Although the panel is useful, it does not provide definitive results in all cases. Our results reveal that the IgG avidity test is the first method that can differentiate between recent and more distant infection in a single serum sample if the sample is obtained in the first trimester of pregnancy. Kits in use in Europe extend this possibility to the fourth month of gestation [14, 18, 20]. Unfortunately, in many instances, the first serum sample is not submitted for testing until later in the pregnancy. The serum samples selected for this study had equivocal or positive results by IgM ELISA or AC/HS test. Additional serum samples from some of the same patients were tested by TSP, but the results did not allow clear-cut discrimination between recently acquired and distant infection. When IgG avidity and IgM ELISA results were compared in serum samples obtained during the first trimester of pregnancy, 51.9% of IgM ELISA positive serum samples (55.9% of IgM-positive and IgM-equivocal serum samples) had high IgG avidity test results that essentially ruled out recent infection. These results highlight the problem in interpretation of a positive test for IgM antibodies without confirmatory testing. In a recent study in which we used the TSP, a positive IgM test result did not indicate a recently acquired infection in 60% of pregnant women studied [24]. Of importance, IgM antibodies may persist for 1 year after acute T. gondii infection. The value of testing for IgG avidity, as shown in the present study, confirms and extends the results reported by Lappalainen et al. [14]. Initial findings with the IgG avidity method suggested that low-avidity antibodies indicated recently acquired infection [14]. Since then, studies have shown clearly that low-avidity antibodies can persist for many months beyond the acute infection and thus are not reliable for the diagnosis of recently acquired infection [20, 25]. In contrast, the consensus appears to be that the IgG avidity test is best used to rule out recently acquired infection. Depending on the method used, the presence of high-avidity IgG antibodies can be used to rule out the occurrence of acute infection within the past 3 5 months (table 4). Thus, its value is greatest when done in the first 3 4 months of gestation. A high-avidity result late in the second trimester or in the third trimester cannot be interpreted to mean that the infection was not acquired in the first 3 5 months of gestation. Of note, 20% of serum samples with a low-avidity result in the present study had negative results in the IgM ELISA; testing of the initial and follow-up serum samples in the TSP did not suggest recently acquired infection in any of these cases. Both the AC/HS test and the IgG avidity test were valuable in confirmatory testing of IgM-positive serum samples, and the 2 methods had excellent agreement (94.9% of serum samples with a nonacute pattern in the AC/HS test had high-avidity antibodies). Discrepant results between the AC/HS and IgG avidity tests only occurred in serum samples with high-avidity antibodies. The high numbers of equivocal results in the avidity and AC/ Table 3. Comparison of IgG avidity test and differential agglutination (AC/HS) test results in 125 serum samples taken from pregnant women during the first trimester. Avidity result Acute (n p 33) AC/HS test result Equivocal (n p 53) Nonacute (n p 39) Low 17 (51.5) 4 (7.5) 0 Borderline 12 (36.4) 18 (34.0) 2 (5.1) High 4 (12.1) 31 (58.5) 37 (94.9) NOTE. Data are no. (%) of serum samples. For further explanation of the AC/HS test, see figure 1.
5 1252 Liesenfeld et al. JID 2001;183 (15 April) Table 4. Study [reference] Reports in the literature on toxoplasma IgG avidity tests. Avidity test type No. and type of serum samples Exclusion period, months Cutoff for high avidity, % Positive predictive value of high avidity, % Comment Lappalainen et al. [14] Noncommercial titration 226 IgG /IgM, including 13 seroconverters % Positive predictive value for low avidity antibodies Holliman et al. [15] Noncommercial 25 Distant infected; 11 recently infected % Negative predictive value for high avidity antibodies Sensini et al. [16] Labsystems 485 Serum samples/308 patients, including 13 seroconverters ND 150 ND Delayed avidity maturation in patients receiving specific treatment Guttiérez et al. [17] ETI-Toxo-G Enzygnost 57 Distant infection 12 seroconverters ND No signficiant differences between methods Jenum et al. [18] Titration (Platelia IgG); 107 recent infections 56 IgG /IgM ND Unchanged avidity maturation in patients receiving specific treatment Ashburn et al. [19] Noncommercial titration 43, Including 1 seroconverter ND 130 ND Pelloux et al. [20] Vidas Seroconverters ND Avidity!30%, even 9 months after infection, in patients with immune disorders and in pregnant women Cozon et al. [25] Enzygnost 493 IgG /IgM % Negative predictive value of low avidity antibodies NOTE. ND, not determined. HS tests remain a drawback of these methods. In cases with equivocal results in either the AC/HS or avidity test (43.2% and 26.4%, respectively), only confirmatory testing by the TSP or testing of follow-up serum samples could help distinguish between recently acquired and distant infection. Interpretation of avidity test methods was based solely on results in serum samples obtained sequentially from pregnant women who seroconverted and not on outcome in their children. Follow-up data in only a small number of children ( n p 13) born to mothers who had high-avidity antibodies in the first trimester have been published elsewhere [26]. None of the 13 was infected with T. gondii, according to long-term serologic follow-up [26]. A question for consideration is whether a high-avidity test result in the first trimester can rule out the possibility of fetal infection in women who acquired the infection a few months before gestation. The likelihood of congenital transmission as a result of an infection acquired in the weeks before or near the time of conception is extremely low, approaching zero [27]. Congenital toxoplasmosis has been reported in only 6 children of women whose serologic test results revealed they probably were infected before pregnancy [1]. Each of these women was infected 1 3 months before becoming pregnant. Avidity testing does not overcome the limitations of serologic testing in this regard. Thus, the dictum that no serologic test is perfect can be extended to the avidity test. No investigators who have developed avidity tests have claimed that their methods can unequivocally rule out infection acquired a few weeks before the beginning of pregnancy. Unfortunately, commercial kits for IgG avidity are not licensed in the United States. This method would be well suited to rule out recently acquired infections in IgM-positive pregnant women who have high-avidity antibodies in their first months of gestation. An approach to testing for and management of T. gondii infection in pregnant women would be to screen for IgG and IgM antibodies in the first trimester of all women in whom the serologic status is not known at conception. For women with negative results in both tests, information and education would be of paramount importance to prevent infection [1]. In serum samples positive for both IgG and IgM antibodies, IgG avidity would be determined. A high-avidity test result would decrease significantly the number of additional confirmatory or follow-up serologic tests needed and the need for spiramycin and invasive techniques, including polymerase chain reaction (PCR) analysis of amniotic fluid. These findings were emphasized further by our experience in the present study: even in the setting of a reference laboratory in which TSP is used to distinguish between recently acquired and distant infection, high-avidity antibodies were detected in 17.5% of 40 women for whom spiramycin had been recommended, because recently acquired infection could not be ruled out in a single serum sample by the TSP. Since serum samples were chosen retrospectively, all decisions about spiramycin treatment were made without knowledge of avidity test results. Thus, a high-avidity test result in the first trimester decreases the need for follow-up serum samples and thereby reduces costs, rules out the need for PCR analysis of amniotic fluid and the need for treatment of the mother with spiramycin, removes the anxiety associated with further testing, and lessens the likelihood of misdiagnosis [24]. Whether the avidity test can replace any of the present tests in the TSP or should simply be added to that panel requires further evaluation of the avidity tests being marketed. At present no avidity test has been released by the Food and Drug Administration for US marketing. We now routinely use the avidity
6 JID 2001;183 (15 April) Toxoplasma IgG Avidity 1253 test as an additional diagnostic tool in the TSP for patients with a positive or equivocal IgM test or acute or equivocal pattern by AC/HS test. We conclude that IgG avidity testing of serum samples of women in the first trimester of pregnancy is a valuable confirmatory test for the exclusion of recently acquired T. gondii infection, especially in US laboratories, which usually have only a single serum sample for testing. Acknowledgments We greatly appreciate the help of Meg Davis and Raymund Ramirez (Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, CA). References 1. Remington JS, Klein JO. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: WB Saunders, Wong S, Remington JS. Toxoplasmosis in pregnancy. Clin Infect Dis 1994; 18: Aspock H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl 1992;84: Daffos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988; 318: Bobic B, Sibalic D, Djurkovic-Djakovic O. High levels of IgM antibodies specific for Toxoplasma gondii in pregnancy 12 years after primary toxoplasma infection. Gynecol Obstet Invest 1991;31: Del Bono V, Canessa A, Bruzzi P, Fiorelli MA, Terragna A. Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy. J Clin Microbiol 1989;27: Sabin AB, Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite (toxoplasma). Science 1948; 108: Dannemann BR, Vaughan WC, Thulliez P, Remington JS. Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol 1990;28: Stepick-Biek P, Thulliez P, Araujo FG, Remington JS. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis 1990;162: Wong SY, Hajdu MP, Ramirez R, Thulliez P, McLeod R, Remington JS. Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis. J Clin Microbiol 1993;31: Liesenfeld O, Press C, Flanders R, Ramirez R, Remington JS. Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis. J Clin Microbiol 1996;34: Montoya JG, Remington JS. Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin Infect Dis 1995;20: Hedman K, Lappalainen M, Seppaia I, Makela O. Recent primary Toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 1989;159: Lappalainen M, Koskela P, Koskiniemi M, et al. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis 1993;167: Holliman RE, Raymond R, Renton N, Johnson JD. The diagnosis of toxoplasmosis using IgG avidity. Epidemiol Infect 1994;112: Sensini A, Pascoli S, Marchetti D, et al. IgG avidity in the serodiagnosis of acute Toxoplasma gondii infection: a multicenter study. Clin Microbiol Infect 1996;2: Gutiérrez J, Rodríguez M, Piédrola G, del Carmen-Maroto M. Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis. Clin Microbiol Infect 1997;3: Jenum PA, Stray-Pedersen B, Gundersen AG. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G activity. J Clin Microbiol 1997;35: Ashburn D, Joss AW, Pennington TH, Ho-Yen DO, et al. Do IgA, IgE, and IgG avidity tests have any value in the diagnosis of toxoplasma infection in pregnancy? J Clin Pathol 1998;51: Pelloux H, Brun E, Vernet G, et al. Determination of anti Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (BioMérieux). Diagn Microbiol Infect Dis 1998;32: Hedman K, Lappalainen M, Söderlund M, Hedman L. Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol 1993;4: Naot Y, Remington JS. An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis. J Infect Dis 1980;142: Suzuki Y, Thulliez P, Desmonts G, Remington JS. Antigen(s) responsible for immunoglobulin G responses specific for the acute stage of Toxoplasma infection in humans. J Clin Microbiol 1988;26: Liesenfeld O, Montoya JG, Tathieneni NJ, et al. Confirmatory serologic testing for acute toxoplasmosis reduces rates of induced abortions among women reported to have positive toxoplasma immunoglobulin M antibody tests. Am J Obstet Gynecol 2001;184: Cozon GJ, Ferrandiz J, Nebhi H, Wallon M, Peyron F. Estimation of the avidity of immunoglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women. Eur J Clin Microbiol Infect Dis 1998;17: Lappalainen M, Koskiniemi M, Hiilesmaa V, et al. Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. The Study Group. Pediatr Infect Dis J 1995; 14: Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med 1994;331:695 9.
VIDAS Test for Avidity of Toxoplasma-Specific Immunoglobulin G for Confirmatory Testing of Pregnant Women
JOURNAL OF CLINICAL MICROBIOLOGY, July 2002, p. 2504 2508 Vol. 40, No. 7 0095-1137/02/$04.00 0 DOI: 10.1128/JCM.40.7.2504 2508.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationReceived 8 April 1996/Returned for modification 19 June 1996/Accepted 15 July 1996
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1996, p. 2526 2530 Vol. 34, No. 10 0095-1137/96/$04.00 0 Copyright 1996, American Society for Microbiology Study of Abbott Toxo IMx System for Detection of Immunoglobulin
More informationEvaluation of the Immunoglobulin G Avidity Test for Diagnosis of Toxoplasmic Lymphadenopathy
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 2004, p. 4627 4631 Vol. 42, No. 10 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.10.4627 4631.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationFalse-Positive Results in Immunoglobulin M (IgM) Toxoplasma Antibody Tests and Importance of Confirmatory Testing: the Platelia Toxo IgM Test
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1997, p. 174 178 Vol. 35, No. 1 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology False-Positive Results in Immunoglobulin M (IgM) Toxoplasma
More informationImmunoglobulin M Toxoplasma Antibodies
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, JUlY 1994, p. 401-405 Vol. 1, No. 4 1071-412X/94/$04.00+0 Copyright C) 1994, American Society for Microbiology The Vitek Immunodiagnostic Assay for Detection
More informationSignificance of a positive Toxoplasma Immunoglobulin M test result. in the United States
JCM Accepted Manuscript Posted Online 9 September 2015 J. Clin. Microbiol. doi:10.1128/jcm.01663-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 Significance of a positive
More informationImproved Diagnosis of Primary Toxoplasma gondii Infection in Early Pregnancy by Determination of Antitoxoplasma Immunoglobulin G Avidity
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1997, p. 1972 1977 Vol. 35, No. 8 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Improved Diagnosis of Primary Toxoplasma gondii Infection
More informationDetection of Immunoglobulin M Antibodies Specific for Toxoplasma gondii with Increased Selectivity for Recently Acquired Infections
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2004, p. 5705 5709 Vol. 42, No. 12 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.12.5705 5709.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationDevelopment of Specific Immunoglobulins G, M, and A Following Primary Toxoplasma gondii Infection in Pregnant Women
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1998, p. 2907 2913 Vol. 36, No. 10 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Development of Specific Immunoglobulins
More informationLaboratory Diagnosis of Toxoplasma gondii Infection and Toxoplasmosis
S73 Laboratory Diagnosis of Toxoplasma gondii Infection and Toxoplasmosis Jose G. Montoya Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto,
More informationSimplified Assay for Measuring Toxoplasma gondii Immunoglobulin G Avidity
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Sept. 2001, p. 904 908 Vol. 8, No. 5 1071-412X/01/$04.00 0 DOI: 10.1128/CDLI.8.5.904 908.2001 Copyright 2001, American Society for Microbiology. All Rights
More informationNon-commercial use only
Microbiologia Medica 2017; volume 32:6583 Evaluation of the TGS TA system for the detection of anti-toxoplasma antibodies Olivia Arpino, Annalisa Cianflone, Maria Teresa Manco, Alessia Paganini, Massimo
More informationComparison of the efficiency of two commercial kits ELFA and Western blot in estimating the phase of Toxoplasma gondii infection in pregnant women
Annals of Agricultural and Environmental Medicine 2016, Vol 23, No 4, 570 575 www.aaem.pl ORIGINAL ARTICLE Comparison of the efficiency of two commercial kits ELFA and Western blot in estimating the phase
More informationTELEFAX. Toxoplasma Serology Laboratory (TSL) DATE: TO: FAX: FROM:
TELEFAX DATE: TO: FAX: FROM: Toxoplasma Serology Laboratory RE: SPECIMEN REQUIREMENTS AND TESTING INFORMATION (effective 1/15/16) THIS TRANSMISSION CONSISTS OF 16 PAGES INCLUDING THIS COVER PAGE. IF THERE
More informationModification and Evaluation of Avidity IgG Testing for Differentiating of Toxoplasma gondii Infection in Early Stage of Pregnancy
Original Article Modification and Evaluation of Avidity IgG Testing for Differentiating of Toxoplasma gondii Infection in Early Stage of Pregnancy Mohammad Reza Bonyadi, M.D. 1 *, Parvin Bastani, M.D.
More informationReliable screening for early diagnosis
Elecsys TORCH panel Reliable screening for early diagnosis Toxoplasmosis Rubella HSV CMV Toxoplasmosis The safe and sure approach to Toxo screening Ultrasensitive Toxo IgM optimized to detect all potential
More informationLecture-7- Hazem Al-Khafaji 2016
TOXOPLASMOSIS Lecture-7- Hazem Al-Khafaji 2016 TOXOPLASMOSIS It is a disease caused by Toxoplasma gondii which is a protozoan parasite that is infects a variety of mammals and birds throughout the world.
More informationToxoplasmosis: Summary of evidences, a Research line
Toxoplasmosis: Summary of evidences, a Research line José G. Montoya, MD Associate Professor of Medicine Associate Chief for Clinical Affairs Division of Infectious Diseases Stanford University School
More informationRole of Specific Immunoglobulin E in Diagnosis of Acute Toxoplasma Infection and Toxoplasmosis
JOURNL OF CLINICL MICROBIOLOGY, Nov. 199, p. 2952-2959 95-117/9/112952-8$2./ Copyright 199, merican Society for Microbiology Vol. 1, No. 11 Role of Specific Immunoglobulin in Diagnosis of cute Toxoplasma
More informationOcular Toxoplasmosis - A Laboratory View. Chatterton JMW* Evans R. Ho-Yen DO
Ocular Toxoplasmosis - A Laboratory View Chatterton JMW* Evans R Ho-Yen DO Scottish Toxoplasma Reference Laboratory Microbiology Department Raigmore Hospital Inverness IV UJ * corresponding author Introduction
More informationUniversity of Perugia, Experimental Medicine and Biochemical Sciences, Perugia, Italy
REVIEW 10.1111/j.1469-0691.2006.01444.x Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis A. Sensini University of Perugia, Experimental Medicine and Biochemical
More informationUtility of Immunoblotting for Early Diagnosis of Toxoplasmosis Seroconversion in Pregnant Women
CLINICAL AND VACCINE IMMUNOLOGY, Nov. 2011, p. 1908 1912 Vol. 18, No. 11 1556-6811/11/$12.00 doi:10.1128/cvi.05303-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Utility of
More informationDetection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis
ORIGINAL ARTICLE Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis Josk Gutikrrex, Marla Rodrkuex, Gonxalo Pie drola and Marla del Carmen Maroto Microbiology
More informationpatient's serum is separated from other serum components by selective absorption of the IgM
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1981, p. 486-491 0095-1137/81/1 10486-06$02.00/0 Vol. 14, No. 5 Immunoglobulin M-Immunosorbent Agglutination Assay for Diagnosis of Infectious Diseases: Diagnosis
More informationagglutination assay (ISAGA) for detecting toxoplasma specific IgM
J Clin Pathol 1989;42:1291-1295 Assessment of immunoglobulin-m immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM KIM T DUFFY, P J WHARTON, JULIE D JOHNSON, LINDA NEW, R E
More informationFirst Department of Microbiology, School of Medicine, Aristotle University of Thessaloniki, Greece
ORIGINAL ARTICLE 10.1111/j.1469-0691.2005.01193.x Seroprevalence of Toxoplasma gondii in northern Greece during the last 20 years E. Diza, F. Frantzidou, E. Souliou, M. Arvanitidou, G. Gioula and A. Antoniadis
More informationContribution of IgG avidity and PCR for the early diagnosis of toxoplasmosis in pregnant women from the North-Eastern region of Algeria.
Contribution of IgG avidity and PCR for the early diagnosis of toxoplasmosis in pregnant women from the North-Eastern region of Algeria. Hajira Berredjem 1,2, Hayette Aouras 3, Meriem Benlaifa 2, Imène
More informationPerformance of the BioPlex 2200 flow immunoassay (Bio- Rad) in critical cases of serodiagnosis of toxoplasmosis
CVI Accepts, published online ahead of print on 29 January 2014 Clin. Vaccine Immunol. doi:10.1128/cvi.00624-13 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 3 Performance
More informationAutomated microparticle enzyme immunoassays
238 Infectious Diseases and Immunology, Diagnostic Division, Abbott Laboratories, North Chicago, Illinois 60064, USA J W Safford G G Abbott M C Craine R G MacDonald Correspondence to: J W Safford Abbott
More informationComparative evaluation of AxSYM, VIDAS and VIDIA toxoplasmosis reagent performance in a high seroprevalence Latin American country
Artigo Original / Original Article Comparative evaluation of AxSYM, VIDAS and VIDIA toxoplasmosis reagent performance in a high seroprevalence Latin American country Avaliação comparativa entre o desempenho
More informationUKNEQAS Toxoplasma Serology. It is the fault of the kits or is it?
UKNEQAS Toxoplasma Serology It is the fault of the kits or is it? Purpose of the Schemes The Toxoplasma subschemes consist of IgG and IgM and are designed to: Provide information allowing participants
More informationMolecular Markers in Acute and Chronic Phases of Human Toxoplasmosis: Determination of Immunoglobulin G Avidity by Western Blotting
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, May 2000, p. 384 389 Vol. 7, No. 3 1071-412X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Molecular Markers in Acute
More informationToxo IgG. Principle of the Test. Introduction
Toxo IgG E Principle of the Test The ImmunoComb Toxo IgG test is an indirect solid-phase enzyme immunoassay (EIA). The solid phase is a card with 12 projections ("teeth"). Each tooth is sensitized at two
More informationCytomegalovirus IgG, IgM, IgG Avidity II Total automation for accurate staging of infection during pregnancy
Infectious Disease Cytomegalovirus IgG, IgM, IgG Avidity II Total automation for accurate staging of infection during pregnancy FOR OUTSIDE THE US AND CANADA ONLY Confidence in Your Results LIAISON Cytomegalovirus
More informationImmunoglobulin-A detection and the investigation of clinical toxoplasmosis
J. Med. Microbiol. - Vol. 38 (1993), 286-292 1993 The Pathological Society of Great Britain and Ireland Immunoglobulin-A detection and the investigation of clinical toxoplasmosis BINDYA PATEL, YVONNE YOUNG,
More informationEvaluation of IgG Avidity for Diagnosis of Acute Toxoplasma gondii Compared to Nested PCR in Pregnant Women in First Trimester
Journal of Advances in Medicine 3(1), 31-41, June 2014 3 DOI No. 10.5958/2319-4324.2014.01121.3 Evaluation of IgG Avidity for Diagnosis of Acute Toxoplasma gondii Compared to Nested PCR in Pregnant Women
More informationToxoplasmosis Acquired during Pregnancy: Improved Serodiagnosis Based on Avidity of IgG
691 Toxoplasmosis Acquired during Pregnancy: Improved Serodiagnosis Based on Avidity of IgG Maija Lappalainen, Pentti Koskela, Marjaleena Koskiniemi, Pirkko Ammala, Vilho Hiilesmaa, Kari Teramo, Kari O.
More informationInnovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES
Innovation in Diagnostics ToRCH A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES EN TOXOPLASMOSIS Toxoplasmosis is a parasitic disease caused by with the obligate intracellular
More informationToxoplasma gondii IgM (Toxo IgM)
DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com
More informationMethod for Avoiding False-Positive Results Occurring in Immunoglobulin M Enzyme-Linked Immunosorbent Assays
JOURNAL OF CLINICAL MICROBIOLOGY, July 1981, p. 73-78 0095-1 137/81/070073-06$02.00/0 Vol. 14, No. 1 Method for Avoiding False-Positive Results Occurring in Immunoglobulin M Enzyme-Linked Immunosorbent
More informationBio-Rad Laboratories. The Best Protection Whoever You Are. Congenital and Pediatric Disease Testing
Bio-Rad Laboratories I N F E C T I O U S D I S E A S E T E S T I N G The Best Protection Whoever You Are Congenital and Pediatric Disease Testing Bio-Rad Laboratories I N F E C T I O U S D I S E A S E
More informationJack S. Remington, M.D.
Jack S. Remington, M.D. Professor of Medicine, Emeritus Bio ACADEMIC APPOINTMENTS Emeritus Faculty, Acad Council, Medicine HONORS AND AWARDS Distinguished Career Achievement Award, International Immunocompromised
More informationVOL 13, NO 1, JANUREY 2015 SUPPL AL-AZHAR ASSIUT MEDICAL JOURNAL
AL-AZHAR ASSIUT MEDICAL JOURNAL DIAGNOSTIC TESTS TO DETECT RECENT INFECTIONS WITH TOXOPLASMA GONDII IN PREGNANT WOMEN Anwar Hosainy Abo Hashim 1 and Afaf Abdel-Ghany Attya 2 Department of Parasitology,
More informationDetection of acute Toxoplasma gondii infection in pregnant women by IgG avidity and PCR analysis
Tropical Biomedicine 35(4): 908 914 (2018) Detection of acute Toxoplasma gondii infection in pregnant women by IgG avidity and PCR analysis Roozbehani, M. 1, Gharavi, M.J. 2*, Moradi, M. 3 and Razmjou,
More informationEvidence-based diagnosis of toxoplasma infection Evans R, Ho-Yen D O
Evidence-based diagnosis of toxoplasma infection Evans R, Ho-Yen D O Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract
More informationSerology and International units
Serology and International units L. Grangeot-Keros, National Reference Laboratory for Rubella, Virology Department, A. Béclère Hospital, Clamart, France Detection of rubella-specific IgG antibody Assays
More informationLaboratory diagnosis of congenital infections
Laboratory diagnosis of congenital infections Laboratory diagnosis of HSV Direct staining Tzanck test Immunostaining HSV isolation Serology PCR Tzanck test Cell scrape from base of the lesion smear on
More informationA 39 years old HIV-positive black African woman with previously treated cerebral
1 Abstract A 39 years old HIV-positive black African woman with previously treated cerebral toxoplasmosis experienced a foetal intra-uterine death due to congenital toxoplasmosis. This case demonstrates
More informationClinical Value of Specific Immunoglobulin E Detection by Enzyme-Linked Immunosorbent Assay in Cases of Acquired and Congenital Toxoplasmosis
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2003, p. 1681 1686 Vol. 41, No. 4 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.4.1681 1686.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationLaboratory diagnosis of congenital toxoplasmosis. Christelle Pomares, a,b,c,d, Jose G. Montoya a,b
JCM Accepted Manuscript Posted Online 4 May 2016 J. Clin. Microbiol. doi:10.1128/jcm.00487-16 Copyright 2016 Pomares and Montoya. This is an open-access article distributed under the terms of the Creative
More informationDIAGNOSTIC AUTOMATION, INC.
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationPREDICTIVE VALUE OF LATEX AGGLUTINATION TEST IN SEROLOGICAL SCREENING FOR TOXOPLASMA GONDII
PREDICTIVE VALUE OF LATEX AGGLUTINATION TEST IN SEROLOGICAL SCREENING FOR TOXOPLASMA GONDII Yaowalark Sukthana, Thaiyooth Chintana, Waraporn Supatanapong, Chutatip Siripan, Amorn Lekkla and Rachatawan
More informationSee external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationShort Video. shows/monsters-inside- me/videos/toxoplasma-parasite/
The word Toxoplasma Originated from the Greek word toxon, which meant "bow." The Latin word toxicum, which meant "poison." The original Greek meaning is the one used for the word Toxoplasma, meaning "bow
More informationINTERNATIONAL JOURNAL CEUTICAL RESEARCH AND
Research Article CODEN: IJPRNK B. V. Ramana, IJPRBS, 2013; Volume 2(4): 253-258 ISSN: 2277-8713 IJPRBS INTERNATIONAL JOURNAL OF PHARMAC CEUTICAL RESEARCH AND BIO-SCIENCE SEROPREVALENCE OF ACUTE TOXOPLASMOSIS
More informationToxoplasma gondii IgM ELISA Kit
Toxoplasma gondii IgM ELISA Kit Catalog Number KA0226 96 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle
More informationCHEMILUMINESCENCE ENZYME IMMUNOASSAY (CLIA) Toxoplasma IgG. Cat # (20-25 C Room temp.) Volume
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationSee external label 96 tests HSV 2 IgA. Cat #
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationToxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment
For reprint orders, please contact reprints@expert-reviews.com Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment Expert Rev. Anti Infect. Ther. 10(7), 815 828 (2012)
More informationSeroreactivity to and Avidity for Recombinant Antigens in Toxoplasmosis
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Aug. 2005, p. 977 982 Vol. 12, No. 8 1071-412X/05/$08.00 0 doi:10.1128/cdli.12.8.977 982.2005 Copyright 2005, American Society for Microbiology. All Rights
More informationKnowledge-Based Interpretation of Toxoplasmosis Serology Test Results Including Fuzzy Temporal Concepts
Knowledge-Based Interpretation of Toxoplasmosis Serology Test Results Including Fuzzy Temporal Concepts D. Kopecky, A. Rappelsberger M. Hayde, A.-R. Prusa K.-P. Adlassnig Department of Medical Department
More informationToxoplasma gondii IgM ELISA Kit
Toxoplasma gondii IgM ELISA Kit Catalog Number KA0226 96 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 2, March 2014
PRELIMINARY EVALUATION OF CHORUS SYSTEM IN COMPARISON WITH COBAS 6000 SYSTEM FOR DETECTION OF ANTI-TOXOPLASMA-IGM ANTIBODIES BLERTA LAZE* ANILA MITRE** *Dept. of Biology, University Ismail Qemali, Vlora,
More informationLaboratory Diagnosis. Dr. M Saraei
Laboratory Diagnosis of toxoplasmosis Dr. M Saraei Qazvin University of Medical Sciences Toxoplasmosis Toxoplasmosis is caused by Toxoplasma gondii, an obligate intracellular protozoan parasite that infects
More informationClinical Evaluation of a Chemiluminescence Immunoassay for Determination of Immunoglobulin G Avidity to Human Cytomegalovirus
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, July 2004, p. 801 805 Vol. 11, No. 4 1071-412X/04/$08.00 0 DOI: 10.1128/CDLI.11.4.801 805.2004 Copyright 2004, American Society for Microbiology. All Rights
More informationDetection of immunoglobulin G antibodies to Toxoplasma gondii: Evaluation of two commercial immunoassay systems
Journal of Microbiology, Immunology and Infection (211) 44, 21e26 available at www.sciencedirect.com journal homepage: www.e-jmii.com ORIGINAL ARTICLE Detection of immunoglobulin G antibodies to Toxoplasma
More informationSURVEILLANCE OF TOXOPLASMOSIS IN DIFFERENT GROUPS
SURVEILLANCE OF TOXOPLASMOSIS IN DIFFERENT GROUPS Pages with reference to book, From 183 To 186 Mughisuddin Ahmed ( Department of Pathology, Dow Medical College and Basic Medical Sciences Institute, Jinnah
More informationMultiplex Detection of IgM and IgG Class Antibodies to Toxoplasma gondii, Rubella Virus, and Cytomegalovirus Using a Novel Multiplex Flow Immunoassay
CLINICAL AND VACCINE IMMUNOLOGY, Nov. 2010, p. 1734 1738 Vol. 17, No. 11 1556-6811/10/$12.00 doi:10.1128/cvi.00332-10 Copyright 2010, American Society for Microbiology. All Rights Reserved. Multiplex Detection
More informationDirect Agglutination Test for Diagnosis of Toxoplasma Infection: Method for Increasing Sensitivity and Specificity
JOURNAL OF CLINICAL MICROBIOLOGY, June 1980, p. 562-568 0095-1 137/80/06-0562/07$02.00/0 Vol. 11, No.6 Direct Agglutination Test for Diagnosis of Toxoplasma Infection: Method for Increasing Sensitivity
More informationDorota Nowakowska, 1,2 Iris Colón, 3,4 Jack S. Remington, 4,5 Michael Grigg, 6 Elzbieta Golab, 7 J. Wilczynski, 2 and L.
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2006, p. 1382 1389 Vol. 44, No. 4 0095-1137/06/$08.00 0 doi:10.1128/jcm.44.4.1382 1389.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved.
More informationMKT/BF/328
19.06.2013 MKT/BF/328 BIO-FLASH posters presented at ECCMID, 23rd Congress of Clinical Microbiology and Infectious Diseases Evaluation of HBV/HCV/HIV 1+2 Evaluation of TORC panel As you know this year
More informationSee external label 2 C-8 C 96 tests CHEMILUMINESCENCE. CMV IgG. Cat # Step (20-25 C Room temp.) Volume
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationEvaluation of a new ICT test (LDBIO Diagnostics) to detect toxoplasma IgG. and IgM: comparison with the routine Architect technique.
JCM Accepted Manuscript Posted Online 27 September 2017 J. Clin. Microbiol. doi:10.1128/jcm.01106-17 Copyright 2017 American Society for Microbiology. All Rights Reserved. 1 2 Evaluation of a new ICT test
More informationClinical evaluation of the Roche Elecsys CMV IgG Avidity assay
Eur J Clin Microbiol Infect Dis (2014) 33:1365 1369 DOI 10.1007/s10096-014-2080-4 ARTICLE Clinical evaluation of the Roche Elecsys CMV IgG Avidity assay C. Vauloup-Fellous & T. Lazzarotto & M. G. Revello
More informationDetection of acute toxoplasmosis in rural women in Sudan using different diagnostic tests
Vol. 7(46), pp. 5227-5233, 21 November, 2013 DOI: 10.5897/AJMR12.701 ISSN 1996-0808 2013 Academic Journals http://www.academicjournals.org/ajmr African Journal of Microbiology Research Full Length Research
More informationCongenital Toxoplasmosis
Supplement Article Congenital Toxoplasmosis James B. McAuley Rush University Medical Center, Chicago, Illinois Corresponding Author: James B. McAuley, MD, MPH, 1653 W. Congress Parkway, Chicago, IL 60612.
More informationNational Prevalence Estimates for Cytomegalovirus IgM and IgG Avidity and Association between High IgM Antibody Titer and Low IgG Avidity
CLINICAL AND VACCINE IMMUNOLOGY, Nov. 2011, p. 1895 1899 Vol. 18, No. 11 1556-6811/11/$12.00 doi:10.1128/cvi.05228-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. National Prevalence
More informationHerpes Simplex Virus 2 IgM HSV 2 IgM
DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and 116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com
More informationQuestions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection
1 of 5 01/02/2016 20:39 Questions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection Summary CDC has developed interim guidelines for healthcare providers in the United States
More informationAnalele UniversităŃii din Oradea Fascicula: Ecotoxicologie, Zootehnie şi Tehnologii de Industrie Alimentară, 2010
Analele UniversităŃii din Oradea Fascicula: Ecotoxicologie, Zootehnie şi Tehnologii de Industrie Alimentară, 2010 EPIDEMIOLOGICAL AND CLINICO-BIOLOGICAL CORRELATIONS IN THE DIAGNOSIS OF ACHIEVED TOXOPLASMOSIS
More informationImmunoglobulin M from Immunoglobulin G Antibodies
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1980, p. 336-342 0095-1 137/80/09-0336/07$02.00/0 Vol. 12, No. 3 Diagnostic Significance of Immunoglobulin M Antibodies to Toxoplasma gondii Detected After Separation
More informationEtiology. only one antigenic type. humans are its only known reservoir
Rubella( German meas sles ) Etiology Togaviridae family --- genus Rubivirus single-stranded RNA enveloped virus, Its core protein is surrounded by a single-layer lipoprotein envelope with spike-like projections
More informationDetection of Toxoplasma gondii Antigens in Sera and Urine of Experimentally Infected Mice by Capture ELISA
Original Article Detection of Toxoplasma gondii Antigens in Sera and Urine of Experimentally Infected Mice by Capture ELISA F Foroghi parvar, * H Keshavarz, S Shojaee Dept. of Medical Parasitology and
More informationtoxoplasmosis Laboratory techniques in the investigation of immunocompromised. Cancer patients, (PCR). Clinical and radiological findings
Genitourin Med 1992;68:55-59 Public Health Laboratory Service, Toxoplasma Reference Laboratory, St George's Hospital, Blackshaw Road, London, SW17 OQT, UK K F Barker R E Holliman Address correspondence
More informationSeroprevalence of Toxoplasmosis in High School Girls in Fasa District, Iran
Seroprevalence of Toxoplasmosis in High School Girls in Fasa District, Iran Gholamreza Hatam 1*, Azra Shamseddin 2, Farhoud Nikouee 3 1 Department of Parasitology and Mycology, School of Medicine, Shiraz
More informationE. Histolytica IgG ELISA Kit
E. Histolytica IgG ELISA Kit Catalog Number KA3193 96 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of
More informationEnzyme Immunoassay (EIA) for the Detection of Toxoplasma IgG Antibodies in Human Serum. For In Vitro Diagnostic Use Only
TOXOPLASMA IgG EIA ID: Blue Enzyme Immunoassay (EIA) for the Detection of Toxoplasma IgG Antibodies in Human Serum. For In Vitro Diagnostic Use Only 25175 96 Tests CONTENTS 1 - INTENDED USE 2 - SUMMARY
More informationDue to transmission of the apicomplexan protozoan Toxoplasma
Comparison of the Vidas System and Two Recent Fully Automated Assays for Diagnosis and Follow-Up of Toxoplasmosis in Pregnant Women and Newborns Jean-Benjamin Murat, a,b Céline Dard, a Hélène Fricker Hidalgo,
More informationEvaluation of the New Architect Cytomegalovirus Immunoglobulin M (IgM), IgG, and IgG Avidity Assays
JOURNAL OF CLINICAL MICROBIOLOGY, June 2009, p. 1695 1699 Vol. 47, No. 6 0095-1137/09/$08.00 0 doi:10.1128/jcm.02172-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Evaluation
More informationAnnual Report. 1 st April st March Laboratory Service: Toxoplasma gondii. Provider: NHS Highland
Annual Report 1 st April 29-31 st March 21 Laboratory Service: Toxoplasma gondii Provider: NHS Highland Author: Dr D. O. Ho-Yen Director Scottish Toxoplasma Reference Laboratory Date: May 21 1 1. Summary:
More informationIgG Antibodies To Toxoplasma Gondii ELISA Kit Protocol
IgG Antibodies To Toxoplasma Gondii ELISA Kit Protocol (Cat. No.:EK-310-85) 330 Beach Road, Burlingame CA Tel: 650-558-8898 Fax: 650-558-1686 E-Mail: info@phoenixpeptide.com www.phoenixpeptide.com INTENDED
More informationABSTRACT. Introduction
IMPACT OF TOXOPLASMA, RUBELLA, CYTOMEGALO AND HERPES SIMPLEX VIRUSES ON ABORTION PREVALENCE IN WOMEN ATTENDING AZADI TEACHING HOSPITAL IN KIRKUK CITY-2013 Dr. SAMAR KHALEEL-Kirkuk health directorate PR.
More informationTask Force Microbiology: Reimbursement Proposal Template (version 28/01/08) Toxoplasma gondii opsporen van aviditeit van IgG antilichamen
PROPOSAL: SUMMARY X NEW TEST O TEST WITHDRAWAL O CHANGE REIMBURSEMENT RULES OR PRICING Nederlandstalige omschrijving prestatie Toxoplasma gondii opsporen van aviditeit van IgG antilichamen B750 COM BC
More informationPRELIMINARY ASSESSMENT OF ELISA, MAT, AND LAT FOR DETECTING TOXOPLASMA GONDII ANTIBODIES IN PIGS
Bull Vet Inst Pulawy 52, 545-549, 2008 PRELIMINARY ASSESSMENT OF ELISA, MAT, AND LAT FOR DETECTING TOXOPLASMA GONDII ANTIBODIES IN PIGS JACEK SROKA 1,2, TOMASZ CENCEK 1, IRENA ZIOMKO 1, JACEK KARAMON 1,
More informationInt.J.Curr.Microbiol.App.Sci (2018) 7(1):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.373
More informationToxoplasmosis Objective :
Toxoplasmosis Objective : Describe the Life cycle Mention the Infective stages Define Congenital Toxoplasmosis List the Lab.Diagnosis Illustrate the Immunity to Toxoplasmosis Show the relationship between
More informationParvovirus B19 Infection in Pregnancy
Parvovirus B19 Infection in Pregnancy Information Booklet Contents The Virus page 3 Clinical Manifestations page 6 Diagnosis page 8 Patient Management page 10 References page 12 Parvovirus B19 Infection
More informationEvaluation of Confounders in Toxoplasmosis Indirect Fluorescent Antibody Assay
Iranian J Parasitol: Vol., No.4, 2, pp.-2 Iranian J Parasitol Tehran University of Medical Sciences Publication http:// tums.ac.ir Open access Journal at http:// ijpa.tums.ac.ir Iranian Society of Parasitology
More information